159 related articles for article (PubMed ID: 9324787)
1. [The anti-ischemic effect of angiotensin-converting enzyme inhibitors in treating stable stenocardia of effort in middle-aged and elderly patients].
Lazebnik LB; Vertkin AL; Drozdova SL; Konev IuV; Goncharov LF
Ter Arkh; 1996; 68(4):40-2. PubMed ID: 9324787
[No Abstract] [Full Text] [Related]
2. [The efficacy of Capoten in different clinical courses of acute myocardial infarct].
Mikashinovich ZI; Terent'ev VP; Shlyk SV; Suroedova RA; Shepelev AA
Anesteziol Reanimatol; 1996; (5):39-44. PubMed ID: 9027252
[No Abstract] [Full Text] [Related]
3. [The anti-ischemic effects of ACE inhibitors after an acute myocardial infarct].
Rutherford JD
Rev Clin Esp; 1996 Dec; 196(4 Monografico):41-2. PubMed ID: 9139332
[No Abstract] [Full Text] [Related]
4. Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action?
Rutherford JD
Trans Am Clin Climatol Assoc; 1996; 107():57-66; discussion 66-7. PubMed ID: 8725560
[No Abstract] [Full Text] [Related]
5. [Comparative effectiveness of propranolol, nifedipine and their combination in exertion stenocardia patients].
Romakov AIu; Sagirov AM; Sumarokov AB; Mazur NA
Klin Med (Mosk); 1984 Mar; 62(3):71-5. PubMed ID: 6716933
[No Abstract] [Full Text] [Related]
6. [Angiotensin-converting enzyme inhibition and angina pectoris].
Odenthal HJ; Josephs W
Dtsch Med Wochenschr; 1992 Nov; 117(48):1849-53. PubMed ID: 1451651
[No Abstract] [Full Text] [Related]
7. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
[TBL] [Abstract][Full Text] [Related]
8. [The use of angiotensin-converting enzyme inhibitors in patients with ischemic heart disease].
Martsevich SIu; Metelitsa VI; Vakulovskaia MK; Kozyreva MP
Kardiologiia; 1993; 33(3):58-60. PubMed ID: 8377343
[No Abstract] [Full Text] [Related]
9. [Long-term effects of captopril treatment on the course of stable effort angina pectoris and structural-functional characteristics of platelets in patients with hypertension and ischemic heart disease].
Shafer MZh; Gul'tiaeva EP; Gapon LI; Alfimova TV
Ter Arkh; 2001; 73(7):64-7. PubMed ID: 11523414
[TBL] [Abstract][Full Text] [Related]
10. [Anti-ischemic and infarction-reducing effects of angiotensin-converting enzyme inhibitors].
Landmark K; Aursnes I
Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1923-6. PubMed ID: 11488184
[TBL] [Abstract][Full Text] [Related]
11. [A clinico-pharmacological study of the antianginal and anti-ischemic efficacy of a new drug form of diltiazem with delayed release].
Belousov IuB; Upnitskiĭ AA; Sokolov AV; Tishchenkova NF; Karasev AV; Egorova NA
Ter Arkh; 1997; 69(3):61-3. PubMed ID: 9229836
[No Abstract] [Full Text] [Related]
12. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
Edwards RJ; Redwood SR; Lambiase PD; Marber MS
Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027
[TBL] [Abstract][Full Text] [Related]
13. [The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients].
Dunaev VV; Kraĭdashenko OV; Berezin AE
Eksp Klin Farmakol; 1996; 59(1):21-3. PubMed ID: 8704625
[TBL] [Abstract][Full Text] [Related]
14. [The antioxidant protection of the heart by coenzyme Q10 in stable stenocardia of effort].
Kogan AKh; Syrkin AL; Drinitsina SV; Kokanova IV
Patol Fiziol Eksp Ter; 1999; (4):16-9. PubMed ID: 10598457
[TBL] [Abstract][Full Text] [Related]
15. [Control of myocardial ischemia in patients with effort angina and polyvascular atherosclerotic involvement].
Saiutina EV; Chigineva VV; Zolozova EA; Karlova NA; Karlov AA; Pshenitsin AI; Mazur NA
Kardiologiia; 2012; 52(8):15-9. PubMed ID: 23098393
[TBL] [Abstract][Full Text] [Related]
16. Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling.
Solomon SD; Anavekar NS; Greaves S; Rouleau JL; Hennekens C; Pfeffer MA;
J Am Coll Cardiol; 2004 May; 43(9):1511-4. PubMed ID: 15120803
[TBL] [Abstract][Full Text] [Related]
17. [The effect of helium-neon laser irradiation on myocardial and thyroid functions in patients with ischemic heart disease].
Ruzov VI; Rubanova MP; Grigor'ev MIu; Cherkunov KV
Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (5):7-9. PubMed ID: 9446315
[No Abstract] [Full Text] [Related]
18. [The pharmacokinetic interaction of propranolol and nifedipine in patients with angina of effort].
Kukushkin SK; Rumiantsev DO; Belolipetskaia VG; Kokurina EV; Piotrovskiĭ VK; Metelitsa VI
Eksp Klin Farmakol; 1994; 57(1):32-5. PubMed ID: 8142860
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme inhibitors in angina and myocardial infarction. What role will they play in the 1990s?
Ertl G
Drugs; 1993 Aug; 46(2):209-18. PubMed ID: 7691512
[No Abstract] [Full Text] [Related]
20. [The possibilities for the pathogenetic therapy of ischemic heart disease under cardioselective loading].
Ardashev VN; Smirnov AV; Ryndin AA; Shcherbak IuA
Voen Med Zh; 1994 Jul; (7):29-31, 79. PubMed ID: 7810109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
